thin film Archives | Be Korea-savvy
Advanced Energy® Highlights Precision Power and Control Technologies for Semiconductor and Thin-Film Processing Applications at SEMICON® Korea 2017

Advanced Energy® Highlights Precision Power and Control Technologies for Semiconductor and Thin-Film Processing Applications at SEMICON® Korea 2017

SEOUL, South Korea, Feb. 9 (Korea Bizwire) — Advanced Energy Industries, Inc. (Nasdaq:AEIS) will highlight its advanced power and control technologies this week at SEMICON® Korea 2017. Advanced Energy® (AE®) continues to lead in process power performance, serving as a trusted partner in the industry for more than 35 years. The company’s exhibit will include [...]

Advanced Energy Highlights Precision Power and Control Technologies for Semiconductor and Thin-Film Processing Applications at SEMICON® Korea 2016

Advanced Energy Highlights Precision Power and Control Technologies for Semiconductor and Thin-Film Processing Applications at SEMICON® Korea 2016

SEOUL, South Korea, Jan. 27 (Korea Bizwire) — Advanced Energy Industries, Inc. (NasdaqGM:AEIS) today will highlight its advanced power and control technologies at SEMICON® Korea 2016. Among its process power, high voltage power and thermal products on display, the company will feature its new, floating, high voltage bipolar power supply and next-generation high-speed pyrometer. The [...]

RedHill Biopharma and IntelGenx Announce First European Marketing Approval of RIZAPORT™ (RHB-103) for Migraines

RedHill Biopharma and IntelGenx Announce First European Marketing Approval of RIZAPORT™ (RHB-103) for Migraines

TEL-AVIV, Israel, Nov. 9 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), an Israeli biopharmaceutical company primarily focused on late clinical-stage, proprietary, orally-administered, small molecule drugs for inflammatory and gastrointestinal diseases, including cancer, today announced, together with IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a Canadian drug delivery company focused on oral drug [...]